<DOC>
	<DOCNO>NCT00097110</DOCNO>
	<brief_summary>The perinatal morbidity mortality rate Brazil five ten-fold higher report upper income country . This study test likelihood joint administration antioxidant vitamin C ( 1000 mg ) vitamin E ( 400 IU ) reduce incidence preeclampsia among chronically hypertensive pregnant patient patient past history preeclampsia/eclampsia .</brief_summary>
	<brief_title>RCT Antioxidant Therapy Prevent Preeclampsia Brazil</brief_title>
	<detailed_description>The maternal , perinatal neonatal morbidity mortality rate Brazil five ten-fold higher report upper income country . In Sao Paulo , 22 percent maternal death attributable hypertensive complication pregnancy , rank number one cause maternal death . Recent advance understand pathophysiology preeclampsia suggest possibility antioxidant therapy prevention preeclampsia . The primary hypothesis joint administration antioxidant vitamin C ( 1000 mg ) vitamin E ( 400 IU ) reduce incidence preeclampsia among chronically hypertensive pregnant patient patient past history preeclampsia/eclampsia . Secondary outcome include severity preeclampsia ; incidence gestational hypertension ; incidence premature rupture membrane ; incidence preterm birth ; incidence low birth weight infant ; biomarker level correlation preeclampsia . Study sit high-risk obstetrical clinic Brazilian city Recife , Botucatu , Campinas , Porto Alegre . The sample size base estimate risk preeclampsia/eclampsia 21-25 % control group . The study hypothesize 40 % absolute reduction risk preeclampsia ; early treatment withdrawal 3 % ; withdrawal consent loss follow-up 10 % ; calculate 0.05 significance level 80 % power . Seven hundred thirty-four obstetric patient chronic hypertension preeclampsia prior pregnancy present care 12 week 19 week ' , 6 day gestation randomize double-blinded placebo control trial receive daily dose either vitamin E ( 400 International Units ) vitamin C ( 1000 mg ) placebo time enrollment delivery . The use MEMS cap enable researcher accurately track compliance .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>HELLP Syndrome</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Gestational age 12 week 19 week , 6 day , inclusive Chronic hypertension History preeclampsia/eclampsia Attendance participate hospital ( Recife , Botucatu , Campinas Porto Alegre , Brazil ) Planned delivery elsewhere . Multifetal gestation . Allergy vitamin C vitamin E. Requirement aspirin anticoagulant medication . Proteinuria ≥ 2+ dipstick urine test ; proteinuria = 1+ dipstick ≥ 300 mg/24 hour . Prepregnancy diabetes mellitus . Known fetal anomaly incompatible life . Prior participation study . Unwillingness take study medication .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Vitamin C</keyword>
	<keyword>Vitamin E</keyword>
	<keyword>Preeclampsia</keyword>
	<keyword>Antioxidants</keyword>
	<keyword>Global Network</keyword>
	<keyword>Preterm birth</keyword>
	<keyword>Low birth weight infant</keyword>
	<keyword>Brazil</keyword>
	<keyword>Brasil</keyword>
	<keyword>Maternal child health</keyword>
	<keyword>International</keyword>
	<keyword>Women 's health</keyword>
</DOC>